Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that FloQast  is No. 1503 on the annual Inc. 5000 list, the most prestigious ...

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug ...

The Company has over $11.0M in cash and marketable securities on its balance sheet. Trident is fully funded for its upcoming summer drilling program at its flagship Contact Lake Gold Project and is in ...

LONDON/HOUSTON/SINGAPORE, 12 August 2025 – Wood Mackenzie to unveil two additions to its Lens Subsurface  platform at IMAGE 2025, delivering Prospect Valuation and AI-powered Analogues. The new tools ...

BOSTON and LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported financial results and business highlights for ...

The scientific and technical information related to this press release has been reviewed and approved by Mr. Charles Kodors, Manager, International Projects. He is a Professional Geologist registered ...

Marimekko approaches its market areas through key cities. Paris is one of the most important cities on the global fashion scene, and its impact in terms of building brand awareness and positioning ...

Inderes’ revenue grew by 2 percent in July 2025 and was 1.3 (1.3) MEUR.

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") will publish its half-yearly report for the six months ended 30 June 2025 on Friday 15 August 2025 at approximately 9:00 am Finnish time.

SYDNEY, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Axi, a leading force in global financial services, has been honoured with several prestigious accolades at the 2025 Global Business and Finance Magazine ...

The pre-engineering of Factory 02 is progressing – Solar Foods and the City of Lappeenranta, Finland are preparing an agreement to reserve a site for preliminary studies ...

Treatment Arms: Patients in the active treatment arm will receive two 70mg loading doses (Day 1 and Week 8) followed by two 45mg maintenance doses (Week 24 and Week 40). All patients will continue to ...